• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的认知与当前知识:一种神经退行性疾病。

Awareness and current knowledge of Parkinson's disease: a neurodegenerative disorder.

作者信息

Khan Asmat Ullah, Akram Muhammad, Daniyal Muhammad, Zainab Rida

机构信息

a Department of Pharmacology, Laboratory of Neuroanatomy and Neuropsychobiology , Ribeirão Preto Medical School of the University of São Paulo (FMRP-USP) , São Paulo , Brazil.

b Department of Eastern Medicine and Surgery, School of Medical and Health Sciences , The University of Poonch Rawalakot , Rawalakot, Pakistan.

出版信息

Int J Neurosci. 2019 Jan;129(1):55-93. doi: 10.1080/00207454.2018.1486837. Epub 2018 Nov 22.

DOI:10.1080/00207454.2018.1486837
PMID:29883227
Abstract

CONTEXT

Parkinson's disease (PD) is the second common progressive neurodegenerative disease, distressing older men and is prevalent Worldwide.

OBJECTIVES

This article is aimed to review the epidemiology, etiology, pathogenesis, clinical manifestation, diagnosis and management of PD.

METHODS

A google search was performed to recognise studies that review the characteristics of PD. Search terms included 'Parkinson's disease', 'epidemiology', 'etiology', 'pathogenesis', 'clinical manifestations', 'diagnosis' and 'management of Parkinson disease'.

RESULTS

PD is linked to factors such as environmental chemicals, aging, family history and pesticide exposure such as the use of synthetic heroin. PD is characterised clinically by tremors at rest, postural instability, expressionless countenance, lead pipe rigidity and less commonly cognitive impairment. After 60 years of age, PD is commonly prevalent in 1-% of the population, no racial differences are apparent, but the prevalence of PD is more common in men than women. There has also been a better understanding that the disorder may be linked with major non-motor trouble in addition to the additional generally recognised motor complications. There are various management options for the timely management of PD. As the ailment advances, further management strategies are existing; however, the management of non-motor manifestations and late stage motor complications remains mainly testing and will advantage from additional clinical studies.

CONCLUSIONS

In this article, we have discussed current progress in the understanding of the epidemiology, clinical manifestations, pathogenesis and management strategies of the disease.

摘要

背景

帕金森病(PD)是第二常见的进行性神经退行性疾病,困扰着老年男性,在全球范围内普遍存在。

目的

本文旨在综述帕金森病的流行病学、病因、发病机制、临床表现、诊断和管理。

方法

通过谷歌搜索来识别综述帕金森病特征的研究。搜索词包括“帕金森病”“流行病学”“病因”“发病机制”“临床表现”“诊断”和“帕金森病的管理”。

结果

帕金森病与环境化学物质、衰老、家族史以及农药接触(如使用合成海洛因)等因素有关。临床上,帕金森病的特征是静止性震颤、姿势不稳、表情淡漠、铅管样强直,较少见的还有认知障碍。60岁以后,帕金森病在1%的人群中普遍存在,没有明显的种族差异,但男性帕金森病的患病率高于女性。人们也更好地认识到,除了通常公认的运动并发症外,该疾病可能还与主要的非运动问题有关。帕金森病有多种及时管理的选择。随着病情进展,还有进一步的管理策略;然而,非运动表现和晚期运动并发症的管理仍然主要具有挑战性,并且将受益于更多的临床研究。

结论

在本文中,我们讨论了对该疾病的流行病学、临床表现、发病机制和管理策略的理解方面的当前进展。

相似文献

1
Awareness and current knowledge of Parkinson's disease: a neurodegenerative disorder.帕金森病的认知与当前知识:一种神经退行性疾病。
Int J Neurosci. 2019 Jan;129(1):55-93. doi: 10.1080/00207454.2018.1486837. Epub 2018 Nov 22.
2
Overview of Parkinson's disease.帕金森病概述。
Pharmacotherapy. 2007 Dec;27(12 Pt 2):155S-160S. doi: 10.1592/phco.27.12part2.155S.
3
Multifactorial sleep disturbance in Parkinson's disease.帕金森病中的多因素睡眠障碍
Sleep Med. 2017 Jul;35:41-48. doi: 10.1016/j.sleep.2017.03.026. Epub 2017 Apr 25.
4
Parkinson's disease: a review.帕金森病:综述
Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415.
5
Epidemiology of Parkinson's disease.帕金森病的流行病学
J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1.
6
Tremor and Rigidity in Patients with Parkinson's Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors.帕金森病患者的震颤与强直:重点关注流行病学、病理生理学及促成因素
CNS Neurol Disord Drug Targets. 2022;21(7):596-609. doi: 10.2174/1871527320666211006142100.
7
Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis帕金森病:病因、神经病理学及发病机制
8
[Parkinson's disease: pathogenesis, aetiology, symptoms, diagnostics, and its course].[帕金森病:发病机制、病因、症状、诊断及其病程]
Ned Tijdschr Tandheelkd. 2018 Oct;125(10):509-515. doi: 10.5177/ntvt.2018.10.18176.
9
Parkinson disease.帕金森病。
Eur J Neurol. 2020 Jan;27(1):27-42. doi: 10.1111/ene.14108. Epub 2019 Nov 27.
10
Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.帕金森病的分子发病机制、实验模型及新治疗策略
Regen Med. 2007 Jul;2(4):447-55. doi: 10.2217/17460751.2.4.447.

引用本文的文献

1
Precision intervention of virtual reality training for balance and gait in Parkinson's disease: a dose-response meta-analysis.帕金森病平衡和步态虚拟现实训练的精准干预:一项剂量反应荟萃分析。
Front Neurol. 2025 Aug 13;16:1616780. doi: 10.3389/fneur.2025.1616780. eCollection 2025.
2
The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicine.氧化三甲胺在疾病发病机制中的作用及中药的治疗潜力。
Front Pharmacol. 2025 Jul 24;16:1592524. doi: 10.3389/fphar.2025.1592524. eCollection 2025.
3
Repetitive transcranial magnetic stimulation across neurodegenerative diseases: a systematic review and dose-response meta-analysis.
跨神经退行性疾病的重复经颅磁刺激:一项系统评价和剂量反应荟萃分析。
Front Aging Neurosci. 2025 Jul 10;17:1615734. doi: 10.3389/fnagi.2025.1615734. eCollection 2025.
4
Efficacy of repetitive transcranial magnetic stimulation in cognitive impairment of neurodegenerative diseases: a systematic review and meta-analysis.重复经颅磁刺激对神经退行性疾病认知障碍的疗效:一项系统评价和荟萃分析。
BMC Neurol. 2025 Jul 17;25(1):295. doi: 10.1186/s12883-025-04292-4.
5
miR-146a Regulates Neuroinflammation and Immune Cell Function in Neurodegenerative Diseases.微小RNA-146a在神经退行性疾病中调节神经炎症和免疫细胞功能。
Curr Med Sci. 2025 Jul 9. doi: 10.1007/s11596-025-00080-w.
6
Recent advances in targeting LRRK2 for Parkinson's disease treatment.针对帕金森病治疗靶向亮氨酸丰富重复激酶2(LRRK2)的最新进展。
J Transl Med. 2025 Jul 8;23(1):754. doi: 10.1186/s12967-025-06354-0.
7
Correlation between Parkinson's disease subtypes and plasma uric acid/neutrophil-to-lymphocyte ratio.帕金森病亚型与血浆尿酸/中性粒细胞与淋巴细胞比值之间的相关性。
Neurol Sci. 2025 Jun 26. doi: 10.1007/s10072-025-08301-9.
8
Advanced comparative analysis of machine learning algorithms for early Parkinson's disease detection using vocal biomarkers.使用语音生物标志物对早期帕金森病检测的机器学习算法进行高级比较分析。
Digit Health. 2025 Jun 6;11:20552076251342878. doi: 10.1177/20552076251342878. eCollection 2025 Jan-Dec.
9
Unlocking the neuroprotective potential of peptide nucleic acids 5 (PNA5) in neurological diseases: molecular mechanisms to therapeutic approaches.揭示肽核酸5(PNA5)在神经疾病中的神经保护潜力:从分子机制到治疗方法
Metab Brain Dis. 2025 May 29;40(5):213. doi: 10.1007/s11011-025-01629-3.
10
Education Programs for Patients With Parkinson's Disease Receiving Deep Brain Stimulation: A Scoping Review.帕金森病患者接受脑深部电刺激的教育项目:一项范围综述
West J Nurs Res. 2025 Aug;47(8):786-796. doi: 10.1177/01939459251341814. Epub 2025 May 24.